Cytel to hold Complex Innovative Trial Design Symposium18 Oct 2019
Experts to discuss innovative solutions to rare disease clinical trials.
Cytel has announced that the Complex Innovative Trial Design Symposium and East Training will take place 6–7 November at Alexion’s headquarters in Boston, Massachusetts. The event will bring together industry-leading experts to discuss innovative solutions to pressing challenges including rare disease clinical trials.
Cytel has hosted the annual Complex Innovative Trial Design Symposium and East Training since 2011 to connect global thought leaders and innovators from the pharmaceutical industry in order to facilitate the exchange of ideas and reveal new insights on the latest developments in adaptive clinical trial designs. The event also plays a key role in guiding the continual evolution of Cytel’s East platform, the industry-standard software for adaptive clinical trial design and analysis. Amongst the list of guest speakers will be leaders from Pfizer, Takeda and Servier, as well as statistical experts from Cytel, Alexion and Axio.
This year’s symposium will focus on overcoming the acute challenges associated with clinical trials for rare diseases, with an emphasis on how innovative, adaptive clinical trial designs can be exploited to maximize trial efficiency, accommodate specialized data requirements and enhance rare disease trial success rates. The latest insights and detailed case studies will be shared through a series of engaging presentations, and participants will also have the opportunity to actively participate in an East training session on day two.
Currently, rare diseases affect around 350 million patients worldwide, with 90% of rare diseases still without an approved therapy. In addition, scarce patient resources and lack of disease knowledge regarding the best endpoints and treatment effect size makes clinical development for new and effective therapeutics for rare diseases especially difficult.
“To overcome the myriad of clinical trial pain points presented by rare diseases, we need to think creatively and adopt a knowledge-sharing approach to the clinical development process,” said Yannis Jemiai, Chief Scientific Officer at Cytel. “The symposium will offer a key space to facilitate peer-to-peer exchanges, ideation, and sharing of practical solutions. We are driving forward novel experimental designs and statistical approaches for better clinical outcomes in patients with rare disorders.”
Delegates will have the opportunity to learn about a range of novel methodological advancements in the rare disease trial space, including:
The in-depth East software training workshop that will take place on day two will guide participants through the extensive range of powerful trial design tools within East, keeping them up to date on the software platform’s latest developments.
The game is on for connected devices
20 Feb 2020
Global biologics markets, delivery device innovation and smart packaging ‘unpacking’ new growth opportunities for pharma.Read more
CPhI South East Asia rescheduled for July 2020
18 Feb 2020
Event move ensures extra precautions and safety measures takenRead more
Report predicts booming ASEAN generics export market for 2020
13 Feb 2020
The changing opportunities are attributed to rising GMP standards and increased regional harmonization.Read more
Innovation awarded at Pharmapack
10 Feb 2020
Innovations across primary and secondary packaging, drug delivery devices, and machinery acknowledged in Exhibitor Innovations, with Health Product Awards for patient-centricity and eco-design.Read more
Digital value-added medicines - a key driver for 2020
29 Jan 2020
Pharmapack also identifies waste management and the use of blockchain as key trends for the year ahead.Read more
CPhI and AAPS partner to expand expert scientific content at CPhI North America
10 Jan 2020
CPhI and the American Association of Pharmaceutical Scientists (AAPS) today announced a partnership to expand the scientific content of activities sponsored by CPhI, including CPhI North America—the only event to bring the entire North American pharmac...Read more
Innovation and regulatory harmonisation to drive Indian pharma in 2020
18 Dec 2019
Experts suggest the continued goal of aligning India to Western regulatory standards will help the country sustain significant increases in exports.Read more
Connectivity, customization and sustainability driving packaging and drug delivery in 2020
4 Dec 2019
Pharmapack 2020 gathering top specialists and pioneers to exchange their vision on best strategies to tackle key challenges.Read more
Worldwide event predicts global pharma trends for 2020
27 Nov 2019
Content sessions identify value-added medicines, preventive drugs, early diagnostics and patient experience as some of the trends for the year ahead.Read more
India pharma forecast to grow strongly in 2020
22 Nov 2019
The rise in exports growth potential is believed to be in response to concerted reforms by the CDSCO and industry quality improvements in the last few years.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation